Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001363641 | SCV001559762 | uncertain significance | Epileptic encephalopathy | 2023-07-13 | criteria provided, single submitter | clinical testing | An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1055038). This variant has not been reported in the literature in individuals affected with FASN-related conditions. This variant is present in population databases (rs760288450, gnomAD 0.03%). This sequence change replaces valine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 1152 of the FASN protein (p.Val1152Gly). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |